Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × Therapeutics × Clear all

Sponsor

Conditions

Multiple Myeloma 5 Breast Neoplasms 5 Neoplasms 4 Leukemia 4 Brain Neoplasms 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Depression 3 Burkitt Lymphoma 3 Vomiting 2 Nausea 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Mast-Cell 2 Leukemia, Hairy Cell 2

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡